Capstone Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $341K | Buy |
|
|||||
|
2017
Q1 | $287K | Buy |
|
|||||
|
2016
Q4 | $263K | Sell |
|
|||||
|
2016
Q3 | $481K | Sell |
|
|||||
|
2016
Q2 | $588K | Buy |
|
|||||
|
2016
Q1 | $407K | Buy |
|
|||||
|
2015
Q4 | $387K | Buy |
|
|||||
|
2015
Q3 | $232K | Buy |
|
|||||
|
2015
Q2 | $263K | Sell |
|
|||||
|
2015
Q1 | $239K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $209K | Sell |
|
|||||
|
2014
Q1 | $235K | Sell |
|
|||||
|
2013
Q4 | $347K | Buy |
|